Testing effectiveness (Phase 2)Looking for participantsNCT07010237
What this trial is testing
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
Who this might be right for
Sever Aplastic AnaemiaElderly (People Aged 65 or More)Immunosuppressive Treatment
Institute of Hematology & Blood Diseases Hospital, China 65